Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-28 @ 8:42 AM
Study NCT ID:
NCT05877651
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2023-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
Sponsor:
HRYZ Biotech Co.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-15
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-09
First Submit QC Date:
None
Study First Post Date:
2023-05-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-25
Last Update Post Date:
2023-05-30
Last Update Post Date Type:
ACTUAL